A larger study of 40 patients with relapsed CML treated with one of three different doses of CD4+ (i.e. CD8+ depleted) DLI: 0.3, 1.0, or 1.5 x 108 cells/kg (63). This evidence concerns the gene CD4 and chronic myelogenous leukemia, BCR-ABL1 positive.